These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 3733242)
1. Combined hemofiltration and desferrioxamine treatment for aluminum induced osteomalacia. Barré PE; Prichard S Int J Artif Organs; 1986 May; 9(3):167-72. PubMed ID: 3733242 [TBL] [Abstract][Full Text] [Related]
2. Do serum aluminum levels reflect underlying skeletal aluminum accumulation and bone histology before or after chelation by deferoxamine? Hodsman AB; Hood SA; Brown P; Cordy PE J Lab Clin Med; 1985 Dec; 106(6):674-81. PubMed ID: 4067379 [TBL] [Abstract][Full Text] [Related]
3. Aluminum-related osteomalacia: clinical and histological improvement following treatment with desferrioxamine (DFO). Rapoport J; Chaimovitz C; Abulfil A; Mostovlavsky M; Gazit D; Bab I Isr J Med Sci; 1987 Dec; 23(12):1242-6. PubMed ID: 3440748 [TBL] [Abstract][Full Text] [Related]
4. [A case of iron and aluminum related osteomalacia in a long-term hemodialysis patient]. Yamagata K; Kobayashi M; Koyama A; Narita M; Amagai H; Ohno A; Yoshikawa S Nihon Jinzo Gakkai Shi; 1991 Apr; 33(4):437-42. PubMed ID: 1875564 [TBL] [Abstract][Full Text] [Related]
6. Improvement of anemia with deferoxamine in hemodialysis patients with aluminum-induced bone disease. Tielemans C; Collart F; Wens R; Smeyers-Verbeeke J; van Hooff I; Dratwa M; Verbeelen D Clin Nephrol; 1985 Nov; 24(5):237-41. PubMed ID: 4075595 [TBL] [Abstract][Full Text] [Related]
7. Successful treatment of dialysis osteomalacia and dementia, using desferrioxamine infusions and oral 1-alpha hydroxycholecalciferol. Hood SA; Clark WF; Hodsman AB; Bolton CF; Cordy PE; Anderson C; Leung F Am J Nephrol; 1984; 4(6):369-74. PubMed ID: 6517116 [TBL] [Abstract][Full Text] [Related]
8. Treatment of dialysis osteomalacia with desferrioxamine. Brown DJ; Dawborn JK; Ham KN; Xipell JM Lancet; 1982 Aug; 2(8294):343-5. PubMed ID: 6124756 [TBL] [Abstract][Full Text] [Related]
9. Clearance of aluminum by hemodialysis: effect of desferrioxamine. Milliner DS; Hercz G; Miller JH; Shinaberger JH; Nissenson AR; Coburn JW Kidney Int Suppl; 1986 Feb; 18():S100-3. PubMed ID: 3457984 [No Abstract] [Full Text] [Related]
10. Fracture healing with deferoxamine therapy in a patient with aluminum-associated osteomalacia. Phelps KR; Einhorn TA; Vigorita VJ; Lundin AP; Friedman EA ASAIO Trans; 1986; 32(1):198-200. PubMed ID: 3778712 [No Abstract] [Full Text] [Related]
11. Changes in bone histology after treatment with desferrioxamine. Ott SM; Andress DL; Nebeker HG; Milliner DS; Maloney NA; Coburn JW; Sherrard DJ Kidney Int Suppl; 1986 Feb; 18():S108-13. PubMed ID: 3457986 [No Abstract] [Full Text] [Related]
12. Aluminum intoxication in a child: treatment with intraperitoneal desferrioxamine. Warady BA; Ford DM; Gaston CE; Sedman AB; Huffer WE; Lum GM Pediatrics; 1986 Oct; 78(4):651-5. PubMed ID: 3763276 [TBL] [Abstract][Full Text] [Related]
13. Desferrioxamine therapy in hemodialysis patients with aluminum-associated bone disease. Felsenfeld AJ; Rodriguez M; Coleman M; Ross D; Llach F Kidney Int; 1989 Jun; 35(6):1371-8. PubMed ID: 2770115 [TBL] [Abstract][Full Text] [Related]
14. [Osteomalacia induced by aluminum in a patient under chronic hemodialysis: successful treatment with desferrioxamine]. Espinoza O; Gehrung E; Roessler E; Katz E; Pérez A; Delmastro J Rev Med Chil; 1986 Sep; 114(9):867-71. PubMed ID: 3575972 [No Abstract] [Full Text] [Related]
15. Aluminum removal with hemodialysis, hemofiltration and charcoal hemoperfusion in uremic patients after desferrioxamine infusion. A comparison of efficiency. Weiss LG; Danielson BG; Fellström B; Wikström B Nephron; 1989; 51(3):325-9. PubMed ID: 2918944 [TBL] [Abstract][Full Text] [Related]
16. [Renal osteodystrophy (3); its treatment in dialysis patients]. Ghitu S; Oprisiu R; Benamar L; Said S; Tataru Albu A; Arsenescu I; el Esper N; Morinière P; Fournier A Nephrologie; 2000; 21(8):413-24. PubMed ID: 11213385 [TBL] [Abstract][Full Text] [Related]
17. The bone scan in patients with aluminium-associated bone disease. Botella J; Gallego JL; Fernandez-Fernandez J; Sanz-Guajardo D; de Miguel A; Ramos J; Franco P; Enriques R; Sanz-Moreno C Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():403-9. PubMed ID: 3991532 [TBL] [Abstract][Full Text] [Related]
19. Hypercalcaemic osteomalacia and encephalopathy due to aluminium intoxication in haemodialysis patients. Clinical aspects and treatment with desferrioxamine. Mudde AH; Roodvoets AP; Van Groningen K Neth J Med; 1985; 28(1):6-11. PubMed ID: 3974771 [No Abstract] [Full Text] [Related]
20. [Aluminic intoxication in chronic hemodialysis. A diagnosis rarely evoked nowadays. Clinical case and review of the literature]. Seidowsky A; Dupuis E; Drueke T; Dard S; Massy ZA; Canaud B Nephrol Ther; 2018 Feb; 14(1):35-41. PubMed ID: 29174672 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]